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Assessing Chronic Disease Rates through Automated
Pharmacy Data
__________________________________________
It is well known that people with chronic conditions represent the bulk of all health
care needs and associated costs. To set appropriate health care strategies, a crucial
issue for policy makers and health care researchers worldwide is therefore to find
proper methodologies to assess the number of individuals affected by specific chronic
illnesses. Thus far, surveillance studies have been largely used to estimate the health
status of a population because they are fairly inexpensive and data are easy to
collect.
Recently, the analyses of automated pharmacy data have been proposed as an
effective means to measure chronic disease within investigated populations.
Pharmacy data offer several advantages. Prescription data are easily accessible,
inexpensive, precise, and well coded. In addition, drugs prescribed may be
associated, to some extent, with specific chronic conditions. However, few studies
have validated the accuracy of chronic diseases prevalence rates obtained by this
methodology.
The existence of a comprehensive, individual-level linkable pharmacy database of the
approximately 4.0 million inhabitants of Emilia Romagna, a large region in the north
of Italy, provided a unique opportunity to 1) adopt and apply an existing model of
chronic condition identification using Italian pharmacy data, 2) determine rates of
chronic conditions and morbidity within the Emilia Romagna’s population, and 3)
compare the estimated prevalence rates using pharmacy data with those available
from a 2000 Emilia Romagna disease surveillance study. This research has been
jointly conducted by the Department of Health Policy and the Center for Research in
Medical Education and Health Care, supported through a collaborative agreement
with the Agenzia Sanitaria Regionale, Regione Emilia Romagna, and Jefferson
Medical College.1
Using a modified version of the Chronic Disease Score,2 we developed a framework
that identified the use of discrete pharmaceuticals as an indicator of having a chronic
condition. Our framework encompassed important chronic conditions that can be
tracked through the consumption of prescribed pharmaceuticals under the Italian
dispensing system. A clinical review was employed to assure that medication classes
be matched to individuals with chronic conditions and not to incidental users of
pharmaceuticals. To increase specificity, therapeutic classes associated with chronic
conditions needed to be mutually exclusive.
A final list of 31 major chronic condition drug groups (CCDGs) was created. This list
includes primary chronic morbidities, such as cardiovascular diseases and gastric
disorders, as well as other less recurrent disorders, such as gout and Parkinson’s.
Algorithms were then tested on pharmaceutical claims data from Emilia-Romagna
2001 to determine the applicability of our CCDG classification scheme. In 2001, there
were 55.2 million individual prescriptions.
Applying our model, we found that approximately 1.5 million people (37.1% of the
population) were identified as having one or more of the 31 CCDGs. The 31 CCDGs
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accounted for 74.3%of the total number of prescriptions and 76.8% of the total 2001
drug expenditures. Cardiovascular diseases, rheumatologic conditions, gastric
disorders, chronic respiratory illnesses, and psychiatric disorders were the most
frequently occurring chronic diseases. The comparison of rates found through our
algorithms with those available of a 2000 Emilia Romagna disease surveillance study
showed, in most cases, similar prevalence of illnesses, particularly for cardiovascular
diseases, psychiatric disorders, diabetes, benign prostatic hyperplasia, thyroid
disorders, and malignances.
In conclusion, pharmacy data may be a valuable alternative to estimate the extent to
which large populations are affected by chronic conditions. The model for identifying
chronic disease status derived from Italian automated pharmacy data may find
several applications in the healthcare research field. For example, it could be used to
compare morbidity levels in different population groups and to determine the extent
to which the workload of physicians may vary due to patient morbidity differences
beyond those variations attributable to age and gender. It may help detect level of
comorbidity. In addition, it may be used to develop risk adjustment models to
allocate resources in the financing of the Italian health care system.3
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